Lexapro and Death - a phase IV clinical study of FDA data
Death is found among people who take Lexapro, especially for people who are female, 60+ old, have been taking the drug for < 1 month.
The phase IV clinical study is created by eHealthMe based on reports of 71,855 people who have side effects when taking Lexapro from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.
71,855 people reported to have side effects when taking Lexapro.
Among them, 1,468 people (2.04%) died.
What is Lexapro?
Lexapro has active ingredients of escitalopram oxalate. It is often used in depression. eHealthMe is studying from 80,209 Lexapro users for its effectiveness, alternative drugs and more.
Number of Lexapro and Death reports submitted per year:
Time on Lexapro when people died *:
Gender of people who died when taking Lexapro*:
Age of people who died when taking Lexapro *:
Common drugs people take besides Lexapro *:
Common side effects people have before they died *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- O’Brien FE, O’Connor RM, Clarke G, Donovan MD, Dinan TG, Griffin BT, Cryan JF, "The P-glycoprotein inhibitor cyclosporin A differentially influences behavioural and neurochemical responses to the antidepressant escitalopram", Behavioural brain research, 2014 Mar .
Alternative drugs to, pros and cons of Lexapro:
- Lexapro (80,209 reports)
COVID vaccines that are related to Death:
- Death in Moderna COVID Vaccine
- Death in Pfizer BioNTech Covid Vaccine
- Death in Johnson and Johnson Covid Vaccine
Expand to all the drugs that have ingredients of escitalopram oxalate:
- Death and drugs with ingredients of escitalopram oxalate (2,457 reports)
Common drugs associated with Death:
All the drugs that are associated with Death:
- Death (4,263 drugs)
Common conditions associated with Death:
All the conditions that are associated with Death:
- Death (3,693 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on escitalopram oxalate (the active ingredients of Lexapro) and Lexapro (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.